Edoxaban is a medication used in the management and treatment of pulmonary embolism (PE), deep venous thrombosis (DVT), and non-valvular atrial fibrillation (NVAF). It is in the direct-acting oral anticoagulant class of drugs. This activity outlines the indications, action, and contraindications for edoxaban as a valuable agent in treating and managing thromboembolic events. This activity will highlight the mechanism of action, adverse event profile, and other key factors pertinent to the healthcare team members in caring for patients with pulmonary embolism, deep venous thrombosis, and non-valvular atrial fibrillation.

**Objectives:**
- Identify the mechanism of action of edoxaban.
- Summarize the most common adverse events associated with edoxaban therapy.
- Describe the contraindications to using edoxaban.
- Outline some interprofessional team strategies for improving care coordination and communication to patients receiving edoxaban therapy.